A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

NCT05741242 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Solid Tumor

Interventions

BIOLOGICAL: Personalized Synthetic Long Peptide Vaccine

Sponsor

Jaime Leandro Foundation for Therapeutic Cancer Vaccines